Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics

Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics

Date: Thursday, 25 February 2021 - Friday, 26 February 2021
Location: San Diego, California


Conference Chairs

Michael Graner

Michael Graner
Associate Professor, University of Colorado Anschutz School of Medicine

Lucia R. Languino

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Jan L├Âtvall

Jan L├Âtvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

My Mahoney

My Mahoney
Professor and Vice Chair, Thomas Jefferson University

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Dolores Di Vizio

Dolores Di Vizio
Professor, Cedars Sinai Medical Center

Alissa Weaver

Alissa Weaver
Cornelius Vanderbilt Professor of Cell and Developmental Biology, Vanderbilt University Medical Center

Randolph Corteling

Randolph Corteling
Head of Research, ReNeuron Ltd.

Chris Baldwin

Chris Baldwin
Chief Commercial Officer, Exopharm Ltd.

Fatah Kashanchi

Fatah Kashanchi
Professor, George Mason University

Overview

SelectBIO EV-based Diagnostics, Delivery & Therapeutics 2021 Conference, February 25-26, 2021 San Diego brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas:
  • Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
  • Exosome/EV Engineering -- Engineered Exosomes for Delivery
  • Drug Delivery via Engineered Vesicles
  • Exosomes/EV-based Therapeutics Development
  • Exosomes/EVs-derived from Stem Cells and their Role in Regenerative Medicine
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas:
  • Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
  • Role in Cancer and Various Disease Classes
  • Biomarker Potential for Diagnostics Development
  • Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

Registered delegates receive full access to both the co-located concurrent conference tracks, the co-located exhibit hall featuring companies from around the world providing tools/technologies, products and services.

Conference Presentations and Content Organization
  • Circulating Biomarkers 2021
  • EV-based Diagnostics, Delivery and Therapeutics 2021
  • EVs and Stem Cells 2021 -- Speakers from this Topic Area are in Sessions Embedded in the EV-based Diagnostics, Delivery and Therapeutics Track

Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Presentation Submission Deadline: 30 November 2020

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 15 February 2021

Agenda Topics

  • Engineered Exosomes and Extracellular Vesicles (EVs) for Drug Delivery
  • Engineering EVs as Biologic Drugs and Vaccines
  • Ex Vivo Production of Large Quantities of EVs for Therapeutics: Challenges and Opportunities
  • Exosomes-based Diagnostics/Liquid Biopsy Development
    • Diagnostics Markers Carried by Exosomes
    • Liquid Biopsy Enabled by Analyzing Exosome Biomarker Cargo
  • Exosomes/EVs-based Drug Delivery Approaches
  • Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
  • Stem Cell-based EVs for Regenerative Medicine
    • Mesenchymal Stem Cells (MSCs): EVs as a Mediator of Cell Therapy?
  • The Intersection of Exosomes and Viruses
    • Is there a Deep Connection Between Exosomes/EVs and Animal Viruses?

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Johnathon Anderson, Assistant Professor, University of California Davis Health
Rachel DeRita, Director, Extracellular Vesicle Core Facility, University of Pennsylvania School of Veterinary medicine
Jack Keene, James B. Duke Professor, Duke University Medical Center
Aurelio Lorico, Professor of Pathology, Touro University Nevada


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2021-02-25 00:00:002021-02-26 00:00:00Europe/LondonExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and TherapeuticsExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in San Diego, CaliforniaSan Diego, CaliforniaSELECTBIOenquiries@selectbiosciences.com